Blackstone today announced that Blackstone Real Estate Partners VIII L.P. and co-investors have completed their previously announced transaction to sell BioMed Realty, a life science office company, for $14.6 billion to a group led by existing BioMed investors.
Morgan Stanley & Co. LLC served as financial advisor to BREP VIII and completed a “go-shop” process on behalf of BioMed’s selling investors.
READ ALSO : Blackstone to sell BioMed Realty for $14.6bn
Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities LLC also served as financial advisors to BREP VIII, and Eastdil Secured served as financial advisor to the purchasers. Simpson Thacher & Bartlett LLP served as legal advisor to Blackstone.